Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.64851 | 60 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.53734 | 59 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.52863 | 59 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.42806 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.43697 | 58 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.62331 | 59 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.71737 | 61 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.62628 | 61 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.46925 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.47692 | 58 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.56001 | 59 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.45879 | 58 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.56406 | 59 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.62347 | 61 |